γH2AX: A potential DNA damage response biomarker for assessing toxicological risk of tobacco products

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 678, Issue 1, 2009, Pages 43-52

  Albino, Anthony P ^a   Jorgensen, Ellen D ^a   Rainey, Patrick ^a   Gillman, Gene ^a   Clark, T Jeffrey ^b   Gietl, Diana ^a   Zhao, Hong ^c   Traganos, Frank ^c   Darzynkiewicz, Zbigniew ^c  

^a Vector Tobacco Inc   (United States)

^b Liggett Group LLC   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

DNA damage; Double strand breaks; H2AX; Tobacco smoke

Indexed keywords

GAMMA HISTONE H2AX; HISTONE H2AX; TOBACCO SMOKE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; H2AFX PROTEIN, HUMAN; HISTONE; NICOTINE; TAR; TOBACCO TAR;

ARTICLE; CIGARETTE SMOKING; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; GENOTOXICITY; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; PRIORITY JOURNAL; METHODOLOGY; MUTAGEN TESTING; RISK; SMOKING; TUMOR CELL LINE;

MAMMALIA; NEPTUNIA; NICOTIANA TABACUM;

BIOLOGICAL MARKERS; CELL LINE, TUMOR; DNA DAMAGE; HISTONES; HUMANS; MUTAGENICITY TESTS; NICOTINE; RISK; SMOKING; TARS;

EID: 68349127228     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2009.06.009     Document Type: Article

References (96)

1. Herbst R.S., Heymach J.V., and Lippman S.M. Lung cancer. N. Engl. J. Med. 359 (2008) 1367-1380
2. Hughes J.R. The Case for Hardening Those Who Continue to Smoke: Is Achieving Abstinence Harder and Do We Need to Change Our Interventions? (2003), U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute
3. Warner K.E., and Burns D.M. Hardening and the hard-core smoker: concepts, evidence, and implications. Nicotine Tob. Res. 5 (2003) 37-48
4. Gehricke J.-G., Loughlin S.E., Whalen C.K., Potkin S.G., Fallon J.H., Jamner L.D., Belluzzi J.D., and Leslie F.M. Smoking to self-medicate attentional and emotional dysfunctions. Nicotine Tob. Res. 9 (2007) S523-S536
5. Stevens V.L., Bierut L.J., Talbot J.T., Wang J.C., Sun J., Hinrichs A.L., Thun M.J., Goate A., and Calle E.E. Nicotinic receptor gene variants influence susceptibility to heavy smoking. Cancer Epidemiol. Biomarkers Prev. 17 (2008) 3517-3525
6. Stratton K., Shetty P., Wallace R., and Bondurant S. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction (2001), National Academy Press, Washington, DC
7. Hatsukami D., Joseph A.M., LeSage M., Jensen J., Murphy S.E., Pentel P.R., Kotlyar M., Borgida E., Le C., and Hecht S.S. Developing the science base for reducing tobacco harm. Nicotine Tob. Res. 9 (2007) S537-S553
8. Witschi H., Espiritu I., Peake J.L., Wu K., Maronpot R.R., and Pinkerton K.E. The carcinogenicity of environmental tobacco smoke. Carcinogenesis 18 (1997) 575-586
9. Counts M.E., Morton M.J., Laffoon S.W., Cox R.H., and Lipowicz P.J. Smoke composition and predicting relationships for international commercial cigarettes smoked with three machine-smoking conditions. Regul. Toxicol. Pharmacol. 41 (2005) 185-227
10. DeMarini D.M., Gudi R., Szkudlinska A., Rao M., Recio L., Kehl M., Kirby P.E., Polzin G., and Richter P.A. Genotoxicity of 10 cigarette smoke condensates in four test systems: comparisons between assays and condensates. Mutat. Res. 650 (2008) 15-29
11. Rubin H. Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: a bio-historical perspective with updates. Carcinogenesis 22 (2001) 1903-1930
12. Hecht S.S. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat. Rev. Cancer 3 (2003) 733-744
13. Fowles J., and Dybing E. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob. Control 12 (2003) 424-430
14. DeMarini D.M. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat. Res. 567 (2004) 447-474
15. Fujii T., Dracheva T., Player A., Chacko S., Clifford R., Strausberg R.L., Buetow K., Azumi N., Travis W.D., and Jen J. A preliminary transcriptome map of non-small cell lung cancer. Cancer Res. 62 (2002) 3340-3346
16. Sikkink S.K., Liloglou T., Maloney P., Gosney J.R., and Field J.K. In-depth analysis of molecular alterations within normal and tumour tissue from an entire bronchial tree. Int. J. Oncol. 22 (2003) 589-595
17. Guo M., House M.G., Hooker C., Han Y., Heath E., Gabrielson E., Yang S.C., Baylin S.B., Herman J.G., and Brock M.V. Promoter hypermethylation of resected bronchial margins: a field defect of changes?. Clin. Cancer Res. 10 (2004) 5131-5136
18. Kiyohara C., Takayama K., and Nakanishi Y. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer 54 (2006) 267-283
19. Wu X., Gu J., and Spitz M.R. Mutagen sensitivity: a genetic predisposition factor for cancer. Cancer Res. 67 (2007) 3493-3495
20. Elliott B., and Jasin M. Double-strand breaks and translocations in cancer. Cell Mol. Life Sci. 59 (2002) 373-385
21. Masuda A., and Takahashi T. Chromosome instability in human lung cancers: possible underlying mechanisms and potential consequences in the pathogenesis. Oncogene 21 (2002) 6884-6897
22. Mills K.D., Ferguson D.O., and Alt F.W. The role of DNA breaks in genomic instability and tumorigenesis. Immunol. Rev. 194 (2003) 77-95
23. Richardson C., and Jasin M. Frequent chromosomal translocations induced by DNA double-strand breaks. Nature 405 (2000) 697-700
24. West M.H., and Bonner W.M. Histone 2A, a heteromorphous family of eight protein species. Biochemistry 19 (1980) 3238-3245
25. Thatcher T.H., and Gorovsky M.A. Phylogenetic analysis of the core histones H2A, H2B, H3, and H4. Nucleic Acids Res. 22 (1994) 174-179
26. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., and Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol. Chem. 273 (1998) 5858-5868
27. Burma S., Chen B.P., Murphy M., Kurimasa A., and Chen D.J. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem. 276 (2001) 42462-42467
28. Sedelnikova O.A., Rogakou E.P., Panyutin I.G., and Bonner W.M. Quantitative detection of (125)IdU-induced DNA double-strand breaks with gamma-H2AX antibody. Radiat. Res. 158 (2002) 486-492
29. Lee J.H., and Paull T.T. Activation and regulation of ATM kinase activity in response to DNA double-strand breaks. Oncogene 26 (2007) 7741-7748
30. Furuta T., Takemura H., Liao Z.Y., Aune G.J., Redon C., Sedelnikova O.A., Pilch D.R., Rogakou E.P., Celeste A., Chen H.T., Nussenzweig A., Aladjem M.I., Bonner W.M., and Pommier Y. Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes. J. Biol. Chem. 278 (2003) 20303-20312
31. Park E.J., Chan D.W., Park J.H., Oettinger M.A., and Kwon J. DNA-PK is activated by nucleosomes and phosphorylated H2AX within the nucleosomes in an acetylation-dependent manner. Nucleic Acids Res. 31 (2003) 6819-6827
32. Bakkenist C.J., and Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421 (2003) 499-506
33. Lee J.H., and Paull T.T. ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science 308 (2005) 551-554
34. Abraham R.T., and Tibbetts R.S. Cell biology. Guiding ATM to broken DNA. Science 308 (2005) 510-511
35. Ismail I.H., Nystrom S., Nygren J., and Hammarsten O. Activation of ataxia telangiectasia mutated by DNA strand break-inducing agents correlates closely with the number of DNA double strand breaks. J. Biol. Chem. 280 (2005) 4649-4655
36. Rogakou E.P., Boon C., Redon C., and Bonner W.M. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol. 146 (1999) 905-916
37. Rothkamm K., and Lobrich M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low X-ray doses. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 5057-5062
38. MacPhail S.H., Banath J.P., Yu Y., Chu E., and Olive P.L. Cell cycle-dependent expression of phosphorylated histone H2AX: reduced expression in unirradiated but not X-irradiated G1-phase cells. Radiat. Res. 159 (2003) 759-767
39. Banath J.P., and Olive P.L. Expression of phosphorylated histone H2AX as a surrogate of cell killing by drugs that create DNA double-strand breaks. Cancer Res. 63 (2003) 4347-4350
40. Huang X., Traganos F., and Darzynkiewicz Z. DNA damage induced by DNA topoisomerase I- and topoisomerase II-inhibitors detected by histone H2AX phosphorylation in relation to the cell cycle phase and apoptosis. Cell Cycle 2 (2003) 614-619
41. Huang X., Okafuji M., Traganos F., Luther E., Holden E., and Darzynkiewicz Z. Assessment of histone H2AX phosphorylation induced by DNA topoisomerase I and II inhibitors topotecan and mitoxantrone and by the DNA cross-linking agent cisplatin. Cytometry 58A (2004) 99-110
42. Albino A.P., Huang X., Jorgensen E., Yang J., Gietl D., Traganos F., and Darzynkiewicz Z. Induction of H2AX phosphorylation in pulmonary cells by tobacco smoke: a new assay for carcinogens. Cell Cycle 3 (2004) 1062-1068
43. Tanaka T., Huang X., Jorgensen E., Gietl D., Traganos F., Darzynkiewicz Z., and Albino A.P. ATM activation accompanies histone H2AX phosphorylation in A549 cells upon exposure to tobacco smoke. BMC Cell Biol. 8 (2007) 26
44. Jorgensen E.D., Dozmorov I., Frank M.B., Centola M., and Albino A.P. Global gene expression analysis of human bronchial epithelial cells treated with tobacco condensates. Cell Cycle 3 (2004) 1154-1168
45. Albino A.P., Huang X., Jorgensen E.D., Gietl D., Traganos F., and Darzynkiewicz Z. Induction of DNA double-strand breaks in A549 and normal human pulmonary epithelial cells by cigarette smoke is mediated by free radicals. Int. J. Oncol. 28 (2006) 1491-1505
46. Lee J.J., Liu D., Lee J.S., Kurie J.M., Khuri F.R., Ibarguen H., Morice R.C., Walsh G., Ro J.Y., Broxson A., Hong W.K., and Hittelman W.N. Long-term impact of smoking on lung epithelial proliferation in current and former smokers. J. Natl. Cancer Inst. 93 (2001) 1081-1088
47. Hiroshima K., Iyoda A., Shibuya K., Hoshino H., Haga Y., Toyozaki T., Shiba M., Baba M., Fujisawa T., and Ohwada H. Evidence of neoangiogenesis and an increase in the number of proliferating cells within the bronchial epithelium of smokers. Cancer 95 (2002) 1539-1545
48. Muscat J.E., Kleinman W., Colosimo S., Muir A., Lazarus P., Park J., and Richie Jr. J.P. Enhanced protein glutathiolation and oxidative stress in cigarette smokers. Free Radic. Biol. Med. 36 (2004) 464-470
49. Bartkova J., Horejsi Z., Koed K., Kramer A., Tort F., Zieger K., Guldberg P., Sehested M., Nesland J.M., Lukas C., Orntoft T., Lukas J., and Bartek J. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434 (2005) 864-870
50. Gorgoulis V.G., Vassiliou L.V., Karakaidos P., Zacharatos P., Kotsinas A., Liloglou T., Venere M., Ditullio Jr. R.A., Kastrinakis N.G., Levy B., Kletsas D., Yoneta A., Herlyn M., Kittas C., and Halazonetis T.D. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434 (2005) 907-913
51. National Cancer Institute, The FTC cigarette test method for determining tar, nicotine, and carbon monoxide yields of US cigarettes: report of the NCI Expert Committee, National Cancer Institute Smoking and Tobacco Control Monograph 7, National Institutes of Health, Bethesda, MD, 1996.
52. Halicka H.D., Huang X., Traganos F., King M.A., Dai W., and Darzynkiewicz Z. Histone H2AX phosphorylation after cell irradiation with UV-B: relationship to cell cycle phase and induction of apoptosis. Cell Cycle 4 (2005) 339-345
53. Sloan C.H., and Curran J.G. Spectrophotometric determination of filtration of cigarette filters. Tob. Sci. 25 (1981) 57-60
54. Pozarowski P., Holden E., and Darzynkiewicz Z. Laser scanning cytometry: principles and applications. Methods Mol. Biol. 319 (2006) 165-192
55. Zacny J.P., Stitzer M.L., Brown F.J., Yingling J.E., and Griffiths R.R. Human cigarette smoking: effects of puff and inhalation parameters on smoke exposure. J. Pharmacol. Exp. Ther. 240 (1987) 554-564
56. Benowitz N.L. Compensatory smoking of low-yield cigarettes. In: Shopland D.R., Burns D.M., Benowitz N.L., and Amacher R.H. (Eds). Risks Associated with Smoking Cigarettes with Low Machine-measured Yields of Tar and Nicotine (2001), U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bethesda, MD 39-64
57. Hecht S.S., Murphy S.E., Carmella S.G., Li S., Jensen J., Le C., Joseph A.M., and Hatsukami D.K. Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 693-698
58. Hammond D., Fong G.T., Cummings K.M., O'Connor R.J., Giovino G.A., and McNeill A. Cigarette yields and human exposure: a comparison of alternative testing regimens. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 1495-1501
59. Massachusetts Department of Public Health, Testing and Reporting of Constituents of Cigarette Smoke (Proposed Regulations), 105 Code of Massachusetts Regulations 665,000, 1998.
60. Harris J.E. Smoke yields of tobacco-specific nitrosamines in relation to FTC tar level and cigarette manufacturer: analysis of the Massachusetts Benchmark Study. Public Health Rep. 116 (2001) 336-343
61. Kozlowski L.T., Frecker R.C., Khouw V., and Pope M.A. The misuse of 'less-hazardous' cigarettes and its detection: hole-blocking of ventilated filters. Am. J. Public Health 70 (1980) 1202-1203
62. N.L. Benowitz, Biomarkers of cigarette smoking, The FTC cigarette test method for determining tar, nicotine, and carbon monoxide yields of U.S. cigarettes, Report of the NCI Expert Committee, Smoking and Tobacco Control Monograph No. 7, U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bethesda, MD, 1996.
63. Jarvis M.J., Boreham R., Primatesta P., Feyerabend C., and Bryant A. Nicotine yield from machine-smoked cigarettes and nicotine intakes in smokers: evidence from a representative population survey. J. Natl. Cancer Inst. 93 (2001) 134-138
64. Roemer E., Stabbert R., Rustemeier K., Veltel D.J., Meisgen T.J., Reininghaus W., Carchman R.A., Gaworski C.L., and Podraza K.F. Chemical composition, cytotoxicity and mutagenicity of smoke from US commercial and reference cigarettes smoked under two sets of machine smoking conditions. Toxicology 195 (2004) 31-52
65. Health Canada. Determination of 'Tar' Nicotine and Carbon Monoxide in Mainstream Tobacco Smoke (1999), Health Canada, Ottawa
66. Hammond D., Wiebel F., Kozlowski L.T., Borland R., Cummings K.M., O'Connor R.J., McNeill A., Connolly G.N., Arnott D., and Fong G.T. Revising the machine smoking regime for cigarette emissions: implications for tobacco control policy. Tob. Control 16 (2007) 8-14
67. Polzin G.M., Zhang L., Hearn B.A., Tavakoli A.D., Vaughan C., Ding Y.S., Ashley D.L., and Watson C.H. Effect of charcoal-containing cigarette filters on gas phase volatile organic compounds in mainstream cigarette smoke. Tob. Control 17 Suppl. 1 (2008) i10-i16
68. Ginzkey C., Kampfinger K., Friehs G., Kohler C., Hagen R., Richter E., and Kleinsasser N.H. Nicotine induces DNA damage in human salivary glands. Toxicol. Lett. 184 (2009) 1-4
69. Sassen A.W., Richter E., Semmler M.P., Harreus U.A., Gamarra F., and Kleinsasser N.H. Genotoxicity of nicotine in mini-organ cultures of human upper aerodigestive tract epithelia. Toxicol. Sci. 88 (2005) 134-141
70. Polesskaya O.O., Fryxell K.J., Merchant A.D., Locklear L.L., Ker K.F., McDonald C.G., Eppolito A.K., Smith L.N., Wheeler T.L., and Smith R.F. Nicotine causes age-dependent changes in gene expression in the adolescent female rat brain. Neurotoxicol. Teratol. 29 (2007) 126-140
71. Mendes P., Kapur S., Wang J., Feng S., and Roethig H. A randomized, controlled exposure study in adult smokers of full flavor Marlboro cigarettes switching to Marlboro Lights or Marlboro Ultra Lights cigarettes. Regul. Toxicol. Pharmacol. 51 (2008) 295-305
72. Kozlowski L.T., O'Connor R.J., Giovino G.A., Whetzel C.A., Pauly J., and Cummings K.M. Maximum yields might improve public health-if filter vents were banned: a lesson from the history of vented filters. Tob. Control 15 (2006) 262-266
73. Strasser A.A., Ashare R.L., Kozlowski L.T., and Pickworth W.B. The effect of filter vent blocking and smoking topography on carbon monoxide levels in smokers. Pharmacol. Biochem. Behav. 82 (2005) 320-329
74. Wistuba I., Gazdar A.F., and Minna J.D. Molecular genetics of small cell lung carcinoma. Semin. Oncol. 28 (2001) 3-13
75. Chujo M., Noguchi T., Miura T., Arinaga M., Uchida Y., and Tagawa Y. Comparative genomic hybridization analysis detected frequent overrepresentation of chromosome 3q in squamous cell carcinoma of the lung. Lung Cancer 38 (2002) 23-29
76. Bhattacharjee A., Richards W.G., Staunton J., Li C., Monti S., Vasa P., Ladd C., Beheshti J., Bueno R., Gillette M., Loda M., Weber G., Mark E.J., Lander E.S., Wong W., Johnson B.E., Golub T.R., Sugarbaker D.J., and Meyerson M. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 13790-13795
77. Garber M.E., Troyanskaya O.G., Schluens K., Petersen S., Thaesler Z., Pacyna-Gengelbach M., van de R.M., Rosen G.D., Perou C.M., Whyte R.I., Altman R.B., Brown P.O., Botstein D., and Petersen I. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 13784-13789
78. Hanash S., Brichory F., and Beer D. A proteomic approach to the identification of lung cancer markers. Dis. Markers 17 (2001) 295-300
79. Wu X., Zhao H., Wei Q., Amos C.I., Zhang K., Guo Z., Qiao Y., Hong W.K., and Spitz M.R. XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis 24 (2003) 505-509
80. Bonner W.M., Redon C.E., Dickey J.S., Nakamura A.J., Sedelnikova O.A., Solier S., and Pommier Y. GammaH2AX and cancer. Nat. Rev. Cancer 8 (2008) 957-967
81. Rothkamm K., and Lobrich M. Misrepair of radiation-induced DNA double-strand breaks and its relevance for tumorigenesis and cancer treatment (review). Int. J. Oncol. 21 (2002) 433-440
82. Singleton B.K., Griffin C.S., and Thacker J. Clustered DNA damage leads to complex genetic changes in irradiated human cells. Cancer Res. 62 (2002) 6263-6269
83. Robles A.I., Linke S.P., and Harris C.C. The p53 network in lung carcinogenesis. Oncogene 21 (2002) 6898-6907
84. Pfeifer G.P., and Hainaut P. On the origin of G → T transversions in lung cancer. Mutat. Res. 526 (2003) 39-43
85. Zhang P., Wang J., Gao W., Yuan B.Z., Rogers J., and Reed E. CHK2 kinase expression is down-regulated due to promoter methylation in non-small cell lung cancer. Mol. Cancer 3 (2004) 14
86. Leng S., Stidley C.A., Willink R., Bernauer A., Do K., Picchi M.A., Sheng X., Frasco M.A., Van Den B.D., Gilliland F.D., Zima C., Crowell R.E., and Belinsky S.A. Double-strand break damage and associated DNA repair genes predispose smokers to gene methylation. Cancer Res. 68 (2008) 3049-3056
87. Sen B., Mahadevan B., and DeMarini D.M. Transcriptional responses to complex mixtures: a review. Mutat. Res. 636 (2007) 144-177
88. Laugesen M., and Fowles J. Scope for regulation of cigarette smoke toxicity: the case for including charcoal filters. N. Z. Med. J. 118 (2005) U1402
89. Scherer G., Urban M., Engl J., Hagedorn H.W., and Riedel K. Influence of smoking charcoal filter tipped cigarettes on various biomarkers of exposure. Inhal. Toxicol. 18 (2006) 821-829
90. Coggins C.R., and Gaworski C.L. Could charcoal filtration of cigarette smoke reduce smoking-induced disease? A review of the literature. Regul. Toxicol. Pharmacol. 50 (2008) 359-365
91. Hecht S.S. Carcinogen-derived biomarkers and lung cancer. Prev. Med. 25 (1996) 7-9
92. Hatsukami D.K., Lemmonds C., Zhang Y., Murphy S.E., Le C., Carmella S.G., and Hecht S.S. Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products. J. Natl. Cancer Inst. 96 (2004) 844-852
93. Laugesen M., and Fowles J. Marlboro ultrasmooth: a potentially reduced exposure cigarette?. Tob. Control 15 (2006) 430-435
94. Centers for Disease Control and Prevention, Percentage distribution of adult current cigarette smokers, by number of cigarettes smoked per day, and percentage of adult current cigarette smokers who smoked >25 cigarettes per day, by sex, race, Hispanic origin, age, and education. National Health Interview Surveys, selected years-United States, 1974-2000, 2004.
95. Godtfredsen N.S., Prescott E., Vestbo J., and Osler M. Smoking reduction and biomarkers in two longitudinal studies. Addiction 101 (2006) 1516-1522
96. Spitz M.R., Wei Q., Li G., and Wu X. Genetic susceptibility to tobacco carcinogenesis. Cancer Invest. 17 (1999) 645-659